Literature DB >> 16908550

Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity.

Y Hayashida1, T Hirai, S Morishita, M Kitajima, R Murakami, Y Korogi, K Makino, H Nakamura, I Ikushima, M Yamura, M Kochi, J-i Kuratsu, Y Yamashita.   

Abstract

BACKGROUND AND
PURPOSE: On diffusion-weighted imaging (DWI), metastatic tumors of the brain may exhibit different signal intensities (SI) depending on their histology and cellularity. The purpose of our study was to verify the hypotheses (1) that SI on DWI predict the histology of metastases and (2) that apparent diffusion coefficient (ADC) values reflect tumor cellularity.
MATERIALS AND METHODS: We assessed conventional MR images, DWI, and ADC maps of 26 metastatic brain lesions from 26 patients, 13 of whom underwent surgery after the MR examination. Two radiologists performed qualitative assessment by consensus of the SI on DWI in areas corresponding to their enhancing portions. We measured the contrast-to-noise ratio (CNR) on T2-weighted images and normalized ADC (nADC) values, and compared them with tumor cellularity.
RESULTS: The mean SI on DWI and the CNR on T2-weighted images were significantly lower in well differentiated than in poorly differentiated adenocarcinomas and lesions other than adenocarcinoma. The mean nADC value was significantly higher in well differentiated than poorly differentiated adenocarcinomas and lesions other than adenocarcinoma. All 3 small-cell carcinomas and 1 large-cell neuroendocrine carcinoma exhibited high SI on DWI. The nADC value showed a significant inverse correlation with tumor cellularity. There was no significant correlation between the CNR and tumor cellularity.
CONCLUSION: The SI on DWI may predict the histology of metastases; well differentiated adenocarcinomas tended to be hypointense, and small- and large-cell neuroendocrine carcinomas showed hyperintensity. Their ADC values reflect tumor cellularity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908550      PMCID: PMC7977525     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

Review 1.  The new WHO classification of brain tumors.

Authors:  J G Smirniotopoulos
Journal:  Neuroimaging Clin N Am       Date:  1999-11       Impact factor: 2.264

2.  Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions.

Authors:  K Okamoto; J Ito; K Ishikawa; K Sakai; S Tokiguchi
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

Review 3.  Hypointensity on diffusion-weighted MRI of the brain related to T2 shortening and susceptibility effects.

Authors:  Akio Hiwatashi; Toshibumi Kinoshita; Toshio Moritani; Henry Z Wang; David A Shrier; Yuji Numaguchi; Sven E Ekholm; Per-Lennart Westesson
Journal:  AJR Am J Roentgenol       Date:  2003-12       Impact factor: 3.959

Review 4.  Pathology of lung cancer.

Authors:  W A Franklin
Journal:  J Thorac Imaging       Date:  2000-01       Impact factor: 3.000

5.  MR imaging of metastatic GI adenocarcinoma in brain.

Authors:  J C Egelhoff; J S Ross; M T Modic; T J Masaryk; M Estes
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

6.  The role of diffusion-weighted imaging in patients with brain tumors.

Authors:  K Kono; Y Inoue; K Nakayama; M Shakudo; M Morino; K Ohata; K Wakasa; R Yamada
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

7.  Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings.

Authors:  T W Stadnik; C Chaskis; A Michotte; W M Shabana; K van Rompaey; R Luypaert; L Budinsky; V Jellus; M Osteaux
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

Review 8.  Imaging of adult brain tumors.

Authors:  P E Ricci
Journal:  Neuroimaging Clin N Am       Date:  1999-11       Impact factor: 2.264

9.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics.

Authors:  Alexander C Guo; Thomas J Cummings; Rajesh C Dash; James M Provenzale
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

10.  Metastatic adenocarcinoma to the brain: MR with pathologic correlation.

Authors:  D A Carrier; M E Mawad; J B Kirkpatrick; M F Schmid
Journal:  AJNR Am J Neuroradiol       Date:  1994-01       Impact factor: 3.825

View more
  107 in total

1.  Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Authors:  Keiichiro Nakamura; Ikuo Joja; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

2.  Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Joseph A Frank
Journal:  Clin Exp Metastasis       Date:  2011-11-01       Impact factor: 5.150

Review 3.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

4.  Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy.

Authors:  Nkiruka C Atuegwu; Lori R Arlinghaus; Xia Li; E Brian Welch; Bapsi A Chakravarthy; John C Gore; Thomas E Yankeelov
Journal:  Magn Reson Med       Date:  2011-09-28       Impact factor: 4.668

5.  Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.

Authors:  Guido H Jajamovich; Chandni R Valiathan; Razvan Cristescu; Sangeetha Somayajula
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

Review 6.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

7.  Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT.

Authors:  Jing Gu; Pek-Lan Khong; Silun Wang; Queenie Chan; Wailun Law; Jingbo Zhang
Journal:  Mol Imaging Biol       Date:  2010-09-25       Impact factor: 3.488

8.  Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses.

Authors:  Isabelle Thomassin-Naggara; Emile Daraï; Charles A Cuenod; Laure Fournier; Irwin Toussaint; Claude Marsault; Marc Bazot
Journal:  Eur Radiol       Date:  2009-02-13       Impact factor: 5.315

9.  Effects of perfusion on diffusion changes in human brain tumors.

Authors:  Alexander D Cohen; Peter S LaViolette; Melissa Prah; Jennifer Connelly; Mark G Malkin; Scott D Rand; Wade M Mueller; Kathleen M Schmainda
Journal:  J Magn Reson Imaging       Date:  2013-02-06       Impact factor: 4.813

10.  Determination of intra-axial brain tumors cellularity through the analysis of T2 Relaxation time of brain tumors before surgery using MATLAB software.

Authors:  Jamil Abdolmohammadi; Mohsen Shafiee; Fariborz Faeghi; Douman Arefan; Alireza Zali; Rouzbeh Motiei-Langroudi; Zahra Farshidfar; Ali Kiani Nazarlou; Ali Tavakkoli; Mohammad Yarham
Journal:  Electron Physician       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.